Ann: Australian Govt Registers Nuheara to $539m Hearing Program, page-154

Motley Fool says: Should you invest? While I think this is a very promising development and could be the catalyst to a significant lift in sales, it is worth noting that it is a highly competitive market and the list of devices that are included on the HSP is ten pages long. In light of this, I would hold off investing until there is a notably lift in sales. In the meantime, fellow hearing solutions company Cochlear Limited (ASX: COH) could be a better option for investors. Alternatively, these small cap shares could be even better options for investors in 2018.